SEROQUEL XR, created in 2006 (United Kingdom), from 585 sister brands and 17478 competing brands. SEROQUEL XR is owned by ASTRAZENECA, listed on the stock exchange of London Its International Securities Identification Number (ISIN) is GB0009895292. The sector of SEROQUEL XR is Drug Manufacturers.